Captor Therapeutics (WAR:CTX) Total Stockholders Equity : zł69.22 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Captor Therapeutics Total Stockholders Equity?

Captor Therapeutics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was zł69.22 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Captor Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was zł14.90. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Captor Therapeutics's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.05.

Captor Therapeutics Total Stockholders Equity Historical Data

The historical data trend for Captor Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Captor Therapeutics Total Stockholders Equity Chart

Captor Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

4.28

-1.00

124.20

96.32

69.22

Captor Therapeutics Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial														96.32	83.41	55.52	40.83	69.22

Captor Therapeutics (WAR:CTX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Captor Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(69.22	-	0)	/	4.64571
	=	14.90

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Captor Therapeutics's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.531	+	1.247)	/	69.22
	=	0.05

Captor Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Captor Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Captor Therapeutics (WAR:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Captor Therapeutics SA (WAR:CTX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

60Q:Germany

Address

ul. Dunska 11, Wroclaw, POL, 54-427

Website

http://www.captortherapeutics.com

Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.

Captor Therapeutics (WAR:CTX) Headlines

No Headlines